Real-world clinical outcomes in BRCA-positive metastatic breast cancer patients treated in the community oncology setting

被引：0
|
作者：
Houts, Arthur C.
Olufade, Temitope O.
Shenolikar, Rahul
Walker, Mark S.
机构：
[1] Vector Oncol, Memphis, TN USA
[2] AstraZeneca, Gaithersburg, MD USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-09-15
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Eligibility of real-world patients with metastatic breast cancer for clinical trials
    Batra, Atul
    Kong, Shiying
    Cheung, Winson Y.
    BREAST, 2020, 54 : 171 - 178
  • [12] Eligibility of real-world patients with metastatic breast cancer in clinical trials
    Batra, A.
    Kong, S.
    Rigo, R.
    Cheung, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S70 - S70
  • [13] Real-World Baseline Characteristics and Preliminary Outcomes in Patients with Myelofibrosis Treated with Momelotinib in the US Community Oncology Practice Setting
    Fletcher, Luke
    Niehoff, Nicole
    Sura, Sneha
    Liu, Tom
    Todoroff, Karen
    Zhang, William
    Zackon, Ira
    BLOOD, 2024, 144 : 2430 - 2431
  • [14] REAL-WORLD OUTCOMES OF PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA TREATED WITH SECOND-LINE OR LATER CHEMOTHERAPY IN A COMMUNITY ONCOLOGY SETTING IN THE UNITED STATES
    Cowey, C. L.
    Mahnke, L.
    Espirito, J.
    Fox, P.
    Helwig, C.
    Oksen, D.
    Bharmal, M.
    VALUE IN HEALTH, 2016, 19 (07) : A717 - A717
  • [15] Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting
    Moser, Sarah Sharman
    Apter, Lior
    Livnat, Idit
    Ginsburg, Roni
    Yarden, Adva
    Drori, Michal
    Drizon, Anat
    Chodick, Gabriel
    Siegelmann-Danieli, Nava
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 105 - 116
  • [16] Outcome in Patients with Metastatic Breast Cancer Treated with Eribulin: A Real-world Cohort
    Rush, H.
    Khan, M.
    Li, S.
    Agorastos, A.
    Kristeleit, H.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E46 - E46
  • [17] Real-world analysis of eribulin in metastatic breast cancer (MBC): An assessment of time to treatment failure (TTF) in a community oncology setting
    Dranitsaris, George
    Tripathy, Debu
    Beegle, Nancy L.
    Kalberer, Traci L.
    Cox, John David
    Faria, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [18] Real-world evidence of platinum-based chemotherapy for the treatment of BRCA-positive metastatic breast cancer in a cohort of 33,878 women in the United States
    Sebby, Wendy
    Liede, Alexander
    Mazumder, Debasish
    Ghosh, Anirban
    Papademetriou, Eros
    Potluri, Ravi
    Bach, Bruce
    Tyczynski, Jerzy
    CANCER RESEARCH, 2021, 81 (04)
  • [19] Real-world outpatient cost of care among patients with ovarian cancer (OC) treated in the US community oncology setting
    Herms, Lisa
    Shi, Junxin
    Niehoff, Nicole
    Aguilar, Kathleen M.
    Espirito, Janet
    O'Sullivan, Amy
    Su, Zhaohui
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 383 - 384
  • [20] Outpatient cost of care among patients with colorectal cancer (CRC) treated in the real-world US community oncology setting
    Niehoff, Nicole
    Shi, Junxin
    Herms, Lisa
    Aguilar, Kathleen M.
    Espirito, Janet
    O'Sullivan, Amy
    Su, Zhaohui
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 382 - 382
12345